{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:47:22Z","timestamp":1793850442215,"version":"4.6.1"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,1,18]],"date-time":"2010-01-18T00:00:00Z","timestamp":1263772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Acute leukaemias of ambiguous lineage (ALAL) represent a rare type of leukaemia, expressing both myeloid and lymphoid markers. This study retrospectively analyzed data from 92 children (biphenotypic <jats:italic>n<\/jats:italic>\u2003=\u200378, bilineal <jats:italic>n<\/jats:italic>\u2003=\u20036, lineage switch <jats:italic>n<\/jats:italic>\u2003=\u20038) with ALAL registered in the Berlin\u2010Frankf\u00fcrt\u2010M\u00fcnster (BFM) acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL) studies between 1998 and 2006 (2\u00b74% of all cases with acute leukaemia). Our cohort of ALAL patients was characterized by comparatively high median age (8\u00b79\u2003years), high median white blood cell count (14\u00b79\u2003\u00d7\u200310<jats:sup>9<\/jats:sup>\/l), as well as frequent hyperleucocytosis (18\u00b75%) and central nervous system involvement (24\u00b71%). The most frequent cytogenetic abnormalities were <jats:italic>ETV6\/RUNX1<\/jats:italic> fusion (16%) and trisomy 8 (14\u00b76%). Complete remission rate was significantly lower than in ALL\u2010BFM patients (91\u00b78% vs. 99\u00b71%, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7001), but comparable to AML\u2010BFM patients (87\u00b79%). Event\u2010free survival (EFS) and overall survival (OS) of ALAL patients were low, at 62\u2003\u00b1\u20035%. 5\u2010year probability of EFS was significantly worse than in ALL patients (80\u2003\u00b1\u20031%, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7001), but better than for AML patients (49\u2003\u00b1\u20032%, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7027). Our data suggest that an intensive therapy regimen including stem cell transplantation may be favourable for bilineal or lineage switch cases, whereas patients with <jats:italic>ETV6\/RUNX1<\/jats:italic> fusion, lymphoid morphology and patients with expression of cyCD22 and cyCD79a should be treated with an ALL\u2010directed therapy.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2009.08058.x","type":"journal-article","created":{"date-parts":[[2010,1,18]],"date-time":"2010-01-18T09:32:57Z","timestamp":1263807177000},"page":"84-92","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations"],"prefix":"10.1111","volume":"149","author":[{"given":"Heidrun","family":"Gerr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schrappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dworzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf\u2010Dieter","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Bradtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Moericke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Schabath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Creutzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,3,11]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199022000-00001"},{"key":"e_1_2_6_3_1","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukaemias. European Group for the Immunological Characterization of Leukaemias (EGIL)","volume":"9","author":"Bene M.C.","year":"1995","journal-title":"Leukaemia"},{"key":"e_1_2_6_4_1","volume-title":"Acute Leukaemias of Ambiguous Lineage","author":"Brunning R.D.","year":"2001"},{"key":"e_1_2_6_5_1","first-page":"1283","article-title":"Cytogenetic findings in acute biphenotypic leukaemia","volume":"10","author":"Carbonell F.","year":"1996","journal-title":"Leukaemia"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01714978"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403920"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.5037"},{"key":"e_1_2_6_9_1","first-page":"76","article-title":"Lineage switch and multilineage involvement in two cases of pH chromosome\u2010positive acute leukaemia: evidence for a stem cell disease","volume":"79","author":"Cuneo A.","year":"1994","journal-title":"Haematologica"},{"key":"e_1_2_6_10_1","article-title":"The value of c\u2010kit in the diagnosis of biphenotypic acute leukaemia. EGIL (European Group for the Immunological Classification of Leukaemias)","volume":"12","author":"EGIL","year":"1998","journal-title":"Leukaemia"},{"key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1182\/blood.V74.6.2088.2088","article-title":"Molecular heterogeneity in acute leukaemia lineage switch","volume":"74","author":"Gagnon G.A.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_12_1","volume-title":"ISCN 2005: An International System for Human Cytogenetic Nomenclature","author":"ISCN","year":"2005"},{"key":"e_1_2_6_13_1","first-page":"699","article-title":"Outcome of biphenotypic acute leukaemia","volume":"84","author":"Killick S.","year":"1999","journal-title":"Haematologica"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.4312"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00523.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1182\/blood.V71.6.1518.1518","article-title":"Ambiguous phenotypes and genotypes in 16 children with acute leukaemia as characterized by multiparameter analysis","volume":"71","author":"Ludwig W.D.","year":"1988","journal-title":"Blood"},{"key":"e_1_2_6_17_1","first-page":"431","article-title":"Phenotypic and genotypic heterogeneity in infant acute leukaemia. I. Acute lymphoblastic leukaemia","volume":"3","author":"Ludwig W.D.","year":"1989","journal-title":"Leukaemia"},{"key":"e_1_2_6_18_1","volume-title":"Classification of Acute Leukaemias: Perspective I","author":"Ludwig W.D.","year":"2003"},{"key":"e_1_2_6_19_1","first-page":"64","article-title":"Definition of acute biphenotypic leukaemia","volume":"82","author":"Matutes E.","year":"1997","journal-title":"Haematologica"},{"key":"e_1_2_6_20_1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1182\/blood.V66.5.1115.1115","article-title":"Acute mixed lineage leukaemia: clinicopathologic correlations and prognostic significance","volume":"66","author":"Mirro J.","year":"1985","journal-title":"Blood"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-112920"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404128"},{"key":"e_1_2_6_23_1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V75.1.198.198","article-title":"Myeloid\u2010associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukaemia treated with intensive multiagent chemotherapy","volume":"75","author":"Pui C.H.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood.V78.5.1327.1327","article-title":"Characterization of childhood acute leukaemia with multiple myeloid and lymphoid markers at diagnosis and at relapse","volume":"78","author":"Pui C.H.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404613"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-187351"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(88)80170-9"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198704303161802"},{"key":"e_1_2_6_29_1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1182\/blood.V64.3.701.701","article-title":"Lineage switch in acute leukaemia","volume":"64","author":"Stass S.","year":"1984","journal-title":"Blood"},{"key":"e_1_2_6_30_1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow S.H.","year":"2008"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1309\/C38D-D8J3-JU3E-V6EE"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04969.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404848"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199103213241204"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2009.08058.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2009.08058.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:58:43Z","timestamp":1697381923000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2009.08058.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,11]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1111\/j.1365-2141.2009.08058.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2009.08058.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,11]]},"assertion":[{"value":"2010-03-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}